Mankhwala "Lerivon". malangizo ntchito zake.

"Lerivon" - mankhwala zokhudzana antidepressants. Kuti athe timudziwe bwino dongosolo ndi zigawo zake nthawi zonse Ufumuyo mankhwala "Lerivon" malangizo.

Kapangidwe ka "lerivon" ndi yogwira mankhwala mankhwala - mianserin hydrochloride (30 mg), ndi othandiza zosakaniza: mankhwala enaake a stearate, wowuma mbatata, meliltsellyuloza, kalloidny anhydrous silika, calcium mankwala, titaniyamu woipa (E 171), macrogol, hypromellose.

The yogwira thunthu mianserin ukukamba mankhwala piperazino-azepine amene mankhwala zokhudzana antidepressants tricyclic. "Lerivon" oletsedwa alpha2 cholandilira ndi kumabwezera mmbuyo reuptake wa norepinephrine, potero kukula kufala ubongo noradrenergic. Komanso tikudziŵa mogwirizana serotinovymi ndi maselo mu chapakati mantha dongosolo. The mankhwala lili ndi zotsatira anxiolytic, chimene chiri chofunika kwambiri mankhwala a matenda nkhawa ndi matenda tulo, amene amayamba ndi ambiri boma maganizo a munthu.

Mayina mankhwala "Lerivon" mawu akusonyeza kuti mankhwala ndi bwino analekerera ndi odwala matenda a dongosolo mtima, komanso okalamba. Pa mlingo amene therapeutically yabwino "Lerivon" ali pafupifupi ziribe mphamvu pa dongosolo mtima. Iye si achilendo ntchito pa anticholinergic. Iwo ali zotsatira zochepa cardiotoxic mu ambiri osokoneza kuposa antidepressants tritseklicheskie. "Lerivon" sakutanthauza kuti muzikangana antihypertensive ndi wothandizila sympathomimetic.

Ntchito mankhwala "Lerivon 'mu matendawa, wa etiologies zosiyanasiyana. Komabe, pali contraindications ochepa. Pofuna dziŵani ogula ndi iwo Ufumuyo mankhwala "Lerivon" malangizo. Werengani mwatsatanetsatane, inu mukhoza kuwona kuti ndi kosatheka kuvomereza "Lerivon": ngati hypersensitivity kwa thunthu yogwira - mianserin kapena zigawo aliyense ancillary; ndi ana ang'ono kuyerekeza ndi zaka 18; matenda a chiwindi ndi kuphwanya kwambiri chifukwa cha ntchito zake.

CHENJEZO kutenga ndalama izi mankhwala kwa anthu ndi impso kapena chiwindi kulephera, kulephera aakulu mtima, njingayo-kutsekedwa khungu, shuga, Prostatic hypertrophy. Pa nthawi ya mimba ndi mkaka wa m'mawere, amamangiriridwa mankhwala "Lerivon" malangizo limakupatsani ndaphunzira kuti zatsopano inkachitikira pa nyama ndi pamodzi ulemu wa munthu, deta zochepa. Pa mfundo imeneyi, chinapezeka kuti mianserin alibe neontalnogo kapena kuwonongeka intrauterine. Ndipo anapezanso kuti mianserin odzipereka mu mkaka wa m'mawere ndalama kochepa. Komabe, ngakhale tisanasankhe "Lerivon" pamene akudya kapena mimba, muyenera kuyerekeza phindu la mankhwala ndi chiopsezo kuthekera kwa mwana wosabadwayo ndi mwana.

Mungathe kuwerenga za mankhwala mankhwala "Lerivon" ndemanga pamaso ntchito mwachindunji mankhwala. Kuyambira ndemanga mukhoza Nthawi zina mfundo zothandiza. Mwachitsanzo, mukhoza mufunze twangwi ya mavuto: zambiri somnolence; nthawizina kuchuluka thupi; amafotokozedwa kuti nthawi zina kwambiri agranulocytosis, kusintha chitukuko leukopenia, omangana, arthralgia, gynecomastia, edema, kuwonongeka kwa ntchito chiwindi.

Mayina mankhwala "malangizo Lerivon 'ntchito sinafike zolinga kudziletsa mankhwala ndi pakuyenerera yekha. M'pofunika kutenga zimenezo pamaso ntchito mankhwala. Chithandizo zotchulidwa dokotala.